Thromboprophylaxis and thalidomide in the noncancer setting: Toward an algorithm that is based on patient risk factors and underlying disease?
- PMID: 29733935
- DOI: 10.1016/j.jaad.2018.04.049
Thromboprophylaxis and thalidomide in the noncancer setting: Toward an algorithm that is based on patient risk factors and underlying disease?
Comment on
-
Efficacy and tolerance profile of thalidomide in cutaneous lupus erythematosus: A systematic review and meta-analysis.J Am Acad Dermatol. 2018 Feb;78(2):342-350.e4. doi: 10.1016/j.jaad.2017.09.059. Epub 2017 Oct 5. J Am Acad Dermatol. 2018. PMID: 28989111
-
Thalidomide and thromboprophylaxis for dermatologic indications: An unmet need for more evidence.J Am Acad Dermatol. 2018 Sep;79(3):e45-e46. doi: 10.1016/j.jaad.2018.04.048. Epub 2018 May 4. J Am Acad Dermatol. 2018. PMID: 29733936 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources